PDB Short entry for 1SOC HEADER OCTREOTIDE 26-NOV-96 1SOC TITLE NMR STUDY OF THE BACKBONE CONFORMATIONAL EQUILIBRIA OF SANDOSTATIN, TITLE 2 MINIMIZED AVERAGE BETA-SHEET STRUCTURE COMPND MOL_ID: 1; COMPND 2 MOLECULE: SANDOSTATIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: OCTREOTIDE; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1 KEYWDS OCTREOTIDE, SANDOSTATIN EXPDTA SOLUTION NMR AUTHOR G.MELACINI,Q.ZHU,M.GOODMAN REVDAT 4 15-NOV-23 1SOC 1 ATOM REVDAT 3 02-MAR-22 1SOC 1 REMARK LINK REVDAT 2 24-FEB-09 1SOC 1 VERSN REVDAT 1 21-APR-97 1SOC 0 JRNL AUTH G.MELACINI,Q.ZHU,M.GOODMAN JRNL TITL MULTICONFORMATIONAL NMR ANALYSIS OF SANDOSTATIN JRNL TITL 2 (OCTREOTIDE): EQUILIBRIUM BETWEEN BETA-SHEET AND PARTIALLY JRNL TITL 3 HELICAL STRUCTURES. JRNL REF BIOCHEMISTRY V. 36 1233 1997 JRNL REFN ISSN 0006-2960 JRNL PMID 9063871 JRNL DOI 10.1021/BI962497O REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH E.POHL,A.HEINE,G.SHELDRICK,Z.DAUTNER,K.S.WILSON,J.KALLEN, REMARK 1 AUTH 2 W.HUBER,P.J.PFAFFLI REMARK 1 TITL STRUCTURE OF OCTREOTIDE, A SOMATOSTATIN ANALOGUE REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 51 48 1995 REMARK 1 REFN ISSN 0907-4449 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : DISCOVER REMARK 3 AUTHORS : BIOSYM REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: CVFF FORCE FIELD (USED BY DISCOVER) REMARK 3 DGII ALSO WAS USED. REMARK 4 REMARK 4 1SOC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000176448. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 300 REMARK 210 PH : NULL REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : NULL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : ROESY; TOCSY; DQF-COSY REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ REMARK 210 SPECTROMETER MODEL : AMX 500 REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : NULL REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 29 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 1 REMARK 210 CONFORMERS, SELECTION CRITERIA : NULL REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: DMSO-D6 REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2SOC RELATED DB: PDB DBREF 1SOC A 1 8 PDB 1SOC 1SOC 1 8 SEQRES 1 A 8 DPN CYS PHE DTR LYS THR CYS THO MODRES 1SOC DTR A 4 TRP D-TRYPTOPHAN HET DPN A 1 21 HET DTR A 4 24 HET THO A 8 17 HETNAM DPN D-PHENYLALANINE HETNAM DTR D-TRYPTOPHAN HETNAM THO REDUCED THREONINE FORMUL 1 DPN C9 H11 N O2 FORMUL 1 DTR C11 H12 N2 O2 FORMUL 1 THO C4 H11 N O2 SHEET 1 A 2 CYS A 2 PHE A 3 0 SHEET 2 A 2 THR A 6 CYS A 7 -1 O THR A 6 N PHE A 3 SSBOND 1 CYS A 2 CYS A 7 1555 1555 2.01 LINK C DPN A 1 N CYS A 2 1555 1555 1.35 LINK C PHE A 3 N DTR A 4 1555 1555 1.35 LINK C DTR A 4 N LYS A 5 1555 1555 1.34 LINK C CYS A 7 N THO A 8 1555 1555 1.34 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 HETATM 1 N DPN A 1 2.563 -0.779 -7.783 1.00 0.00 N HETATM 2 CA DPN A 1 1.883 0.135 -6.829 1.00 0.00 C HETATM 3 C DPN A 1 1.080 -0.619 -5.721 1.00 0.00 C HETATM 4 O DPN A 1 -0.141 -0.446 -5.648 1.00 0.00 O HETATM 5 CB DPN A 1 2.918 1.181 -6.318 1.00 0.00 C HETATM 6 CG DPN A 1 2.348 2.270 -5.388 1.00 0.00 C HETATM 7 CD1 DPN A 1 2.539 2.186 -4.004 1.00 0.00 C HETATM 8 CD2 DPN A 1 1.613 3.339 -5.914 1.00 0.00 C HETATM 9 CE1 DPN A 1 2.003 3.155 -3.160 1.00 0.00 C HETATM 10 CE2 DPN A 1 1.073 4.304 -5.066 1.00 0.00 C HETATM 11 CZ DPN A 1 1.268 4.211 -3.690 1.00 0.00 C HETATM 12 H2 DPN A 1 3.335 -1.275 -7.324 1.00 0.00 H HETATM 13 H DPN A 1 2.995 -0.244 -8.544 1.00 0.00 H HETATM 14 HA DPN A 1 1.126 0.691 -7.416 1.00 0.00 H HETATM 15 HB2 DPN A 1 3.396 1.679 -7.184 1.00 0.00 H HETATM 16 HB3 DPN A 1 3.757 0.660 -5.817 1.00 0.00 H HETATM 17 HD1 DPN A 1 3.090 1.361 -3.577 1.00 0.00 H HETATM 18 HD2 DPN A 1 1.448 3.418 -6.979 1.00 0.00 H HETATM 19 HE1 DPN A 1 2.146 3.081 -2.091 1.00 0.00 H HETATM 20 HE2 DPN A 1 0.499 5.123 -5.476 1.00 0.00 H HETATM 21 HZ DPN A 1 0.846 4.958 -3.034 1.00 0.00 H